Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
FDA Seeks Info On Harmful Chemicals In JUUL, E-Cigarettes August 5, 2019 Russell Maas Add Your Comments Amid increasing concerns about the health risks with JUUL and other e-cigarette products, federal health officials are requesting public comment on a proposal that would add certain chemicals commonly found in liquid used during vaping to a list of known harmful chemicals from tobacco products. The FDA published a notice in the Federal Register on August 5, requesting public comment on a proposal to add 19 chemicals and compounds to the harmful and potentially harmful constituents (HPHCs) list for chemicals found in tobacco products. The chemicals are those commonly found in vaping e-liquids and electronic cigarette products. Electronic cigarette use, or vaping, has become an increasing trend across the United States over the last decade, impacting a wide variety of the population ranging from middle school age children to adults. While the products were originally marketed as a way to help adults who smoke traditional cigarettes ease off of their addiction to nicotine, trendy marketing campaigns involving JUUL vapes and other products have resulted in a nationwide epidemic of new users being exposed to nicotine and other potentially harmful e-cigarette ingredients. LEARN MORE ABOUT VAPE PEN AND E-CIG LAWSUITS Serious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About VAPE PEN AND E-CIG LAWSUITS Serious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Unlike traditional cigarettes, which have a lengthy documented history of carcinogenics and other unsafe chemicals, vaping liquids have been found to contain new chemical compounds which have not been thoroughly reviewed or tested by the FDA. The agency seeks to determine whether first hand and second hand exposure to these chemicals may cause similar or new adverse health consequences. Currently, tobacco manufacturers must submit ingredient lists to the FDA to determine whether they are safe or require certain warnings for consumers. However, JUUL and other e-cigarette manufacturers do not have to list all of their ingredients on product labels. They are only required to give the FDA information about the levels of HPHCs. Of the 19 chemicals and compounds in question, among them are ethylene glycol, diacetyl and glycidol, which are popular ingredients among e-cigarette liquids. The FDA seeks information to determine whether the list of ingredients have any adverse health effects related to cancer, cardiovascular disease, respiratory effects, developmental or reproductive effects, and addiction. If the agency decides to add the chemicals to the HPHC list, they would then have to put them on product labels. E-cigarette commonly contain artificial flavors, which over history have generally been considered safe for consumption. What is still unknown, is whether they are still safe once they have been heated to certain temperatures and inhaled. The FDA issued the notice shortly after a new study by Yale University researchers identified certain chemicals in Juul vapes that have been associated with lung irritation. Researchers found that eight flavors of Juul e-liquids contained a mixture of solvents that other e-liquids were found not to contain. The FDA is looking for data on the chemicals under consideration, including acetate acid, acetoin, acetyl propionyl, benzyl acetate, butyraldehyde, diacetyl, diethylene glycol, ethyl acetate, ethyl acetoacetate, ethylene glycol, furfural, glycerol, glycidol, isoamyl acetate, isobutyl acetate, methyl acetate, n-Butanol, propionic acid and propylene glycol. The FDA has tentatively concluded these chemicals are mostly respiratory toxicants, but some are suspected of being carcinogens, reproductive or developmental toxicants or poisonous as well. Those who have more scientific data on these chemicals are asked to submit electronic or written comments by October 4, 2019. Comments can be submitted electronically to https://www.regulations.gov. They can be submitted in writing to Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. JUUL Vaping Epidemic Among Teens In recent years, vaping among teens has skyrocketed, and critics say companies targeting adolescent and prior non-smoking populations, promoting use of candy-like e-cigarette flavors and using social media to make vaping look cool and desirable, particularly to young people. The Centers for Disease Control and Prevention (CDC) reports that nearly 14% of middle school students, and 38% of high school students reported having used e-cigarettes. In recent years, a stream of studies, including one in February linking vaping to an increased risk of stroke, have revealed adverse health effects linked to e-cigarettes which were not known when they first hit the market. The FDA, charged with regulating tobacco products, has intensified its efforts to rein in teen vaping, threatening a potential ban on the products if teen use is not curbed. A growing number of families are now filing JUUL injury lawsuits alleging that teens and young adults developed nicotine addictions due to the marketing of the products toward underage users, including several claims that involve seizures, strokes, respiratory problems and other injuries following exposure to chemicals contained in the vaping pods. Written by: Russell Maas Managing Editor & Senior Legal Journalist Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development. Tags: Chemicals, Children, Electronic Cigarettes, Juul, Respiratory, Vaping More JUUL E-Cigarette Vape Lawsuit Stories More Than Half of U.S. Teens Who Vape Do So To Deal With Stress, Anxiety: Study November 18, 2024 On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024 Vaping Causes Same DNA Damage as Smoking, Study Finds April 12, 2024 0 Comments FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: today) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025) Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: yesterday) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025) Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 2 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)
On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: today) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: yesterday) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025)
Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 2 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)